US Patent 10696724 Activatable interleukin-2 polypeptides
Patent 10696724 was granted and assigned to Werewolf Therapeutics on June, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10696724 Activatable interleukin-2 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
